Press Release February 25, 2022Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Patients with Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma. 0 0 Share
Press Release February 25, 2022Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) plus Chemotherapy for First-Line Treatment of Patients with Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma with Tumor Cell PD-L1. 0 0 Share
Company Ticker News February 25, 2022Here's Why Bristol Myers Squibb Stock Is A Better Pick Over This Pharmaceutical Bellwether 0 0 Share
Company Ticker News February 25, 2022S&P Global and IHS Markit Announce Final Regulatory Approval for Merger and Expected Close on February 28, 2022 0 0 Share
Company Ticker News February 25, 2022S&P Global and IHS Markit Announce Final Regulatory Approval for Merger and Expected Close on February 28, 2022 0 0 Share
Press Release February 25, 2022IHS Markit Names General Motors Top Manufacturer for Seventh Consecutive Year in its 26th Annual Automotive Loyalty Awards 0 0 Share
Company Ticker News February 25, 2022Futures Movers: Oil edges lower as traders monitor Russia invasion of Ukraine 0 0 Share
Company Ticker News February 25, 20223 Beaten-Down Stocks Billionaires Are Aggressively Buying 0 0 Share
